The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Directors and Officers
    • The Antibody Society’s Committees
      • AIRR Community Committee
      • Communication & Membership Committee
      • Meetings Committee
    • Sponsors & Partners
  • Society meetings
    • Harnessing Cytokines for Cancer Immunotherapy Symposium
    • Biopharmaceutical Informatics Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2023
      • 2022 Antibody Engineering & Therapeutics
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 2023
    • FOCIS Symposia
  • AIRR Community
    • AIRR News
    • AIRR Publications
    • AIRR Meetings
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-committees
      • Communications Sub-committee
      • Executive Sub-committee
      • Inferred Allele Review Committee
      • Meetings Sub-committee
    • AIRR Data Commons
    • AIRR Community Calendar
    • AIRR Community Webinar Series
    • On AIRR – An AIRR Community Podcast
    • AIRR Community Resources
    • AIRR Community Service Prize 2022
  • Members only
    • Login
    • Note to members
    • James S. Huston Antibody Science Talent Award
      • 2021 James S. Huston Antibody Science Talent Award Recipient
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • JSH Award Criteria
    • Science Writing Competition
      • Science Writing Competition Winners
    • Imaging Competition
    • Research Competitions
      • Research Competition Winners
    • Member discount codes
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics
    • Adaptive Immune Receptor Repertoires
    • Antibody Discovery & Development
    • Commercializing Antibody Therapeutics
    • Antibodies to Watch
    • Antibody Validation
  • COVID-19
    • Guide to “Coronavirus in the Crosshairs”
    • COVID-19 Biologics Tracker
    • Meeting Report: The Diagnostic Landscape for COVID-19
You are here: Home / 2019 Antibody Engineering & Therapeutics

2019 Antibody Engineering & Therapeutics

Antibody Engineering & Therapeutics was held during December 9-13, 2019, in San Diego. The meeting was a great opportunity for Society members to connect with their fellow industry and academic scientists and executives from around the world, and learn about advances in antibody discovery and development.  As always, The Antibody Society’s members designed the scientific program and acted as session Chairs.

Sessions

The following pre-meeting workshops were held on December 9th: Introduction to Antibody Engineering (moderated by David Bramhill, PhD, Bramhill Biological Consulting, LLC); Bispecific Antibodies: New Strategies and Case Studies (moderated by Aran Labrijn, PhD, Genmab); and Machine Learning in Antibody and Protein Engineering (moderated by Sai Reddy, PhD, ETH Zurich and  Andrew Bradbury, MD, PhD, Specifica).

On December 10th, The Antibody Society’s 2019 President Kerry Chester, PhD (UCL Cancer Institute) and Vice President Paul Carter, PhD (Genentech, Inc.) opened the meeting with some inspiring remarks.

Keynotes were delivered by Janine Schuurman, PhD (Genmab), George Georgiou, PhD (The University of Texas at Austin), Gary Nabel, MD, PhD (Sanofi Global R&D), and Marjolein van Egmond, PhD (Amsterdam University Medical Center).

As always, one of the highlights of the conference was the “Antibodies to Watch in 2020” presentation by Janice Reichert, PhD (Executive Director of The Antibody Society, Editor-in-Chief of mAbs).  To update you on 2019 year-end results as well as early 2020 results, we are planning a webinar on ‘Antibodies to Watch in 2020’, which will be available from our Learning Center in early 2020.

Antibody Engineering & Therapeutics Student/Postdoc Poster Competition

To recognize the research activities of promising student/postdoc attendees of the Antibody Engineering & Therapeutics conference, The Antibody Society sponsored a poster competition for students and postdocs. The winners received complimentary registration, support for travel expenses, and an opportunity to present at the conference.
Congratulations to our winners:

Timothy Czajka, University of New York at Albany.
Poster title: RIP-Off: An Intrabody-based Strategy to Neutralize Ricin and other Ribosome-Inactivating Protein (RIP) Toxins.

Kamal Joshi, Genentech.
Poster title: Toward Deeper Understanding of Bispecific Antibodies

Timothy Czajka
Dr. Kamal Joshi

The winners’ award ceremony comments:

Timothy Czajka:
“Thank you again to the Antibody Society for this recognition and opportunity to speak here.  This is my third time attending the Antibody Engineering and Therapeutics conference and each time I’ve learned more than I could possibly remember and return to the lab with a huge surge of excitement and several new ideas that I’d like to apply to my own project.  I’m honored to be able to present my own research this year alongside so many fascinating talks and to be able to engage with many different experts in the field.  I would also like to thank my adviser, Nicholas Mantis, and Anne Messer for their help with my research and encouragement to attend and apply for this award.”

Kamal Joshi:
“It is an honor to receive this award. I would like to thank the judges for conferring this recognition on my work. I would also like to thank the Antibody Society, of course for funding my trip here but more importantly for organizing these fantastic meetings and providing a solid platform for the exchange of the latest information on antibody research and development benefiting all including early stage career scientists like me. It’s a real treat coming back to this meeting every time. Not only do I learn what is ongoing in the field, this meeting also provides me the opportunity to network with fellow scientists and facilitate connections. So again, thank you to the Antibody Society for this award. Thank you all.”

Meeting our members & Networking

The Society’s booth in the exhibit hall was the perfect spot for Society board members and volunteers to meet our members and discuss Society initiatives. The T shirts were very popular again this year – come to the booth early next time if you missed your chance to get one.
There were also lots of chances to have discussions with our corporate sponsors and fun at their booths!

 

 

At the Twist Bioscience booth
At the OmniAb booth
At the Ablexis / AlivaMab booth

At ImmunoPrecise’s booth
At Trianni’s booth
At Aldevron’s booth

Informa Connect brings it all together!

We thank the fabulous folks at Informa Connect, Frances Pratt, Michael Keenan (and colleagues not seen here), for their fantastic management of the AE&T meeting!

Our fabulous conference managers

We look forward to seeing you in sunny San Diego at the 2020 AE&T meeting!

mabs

mabs

The Official Journal of The Antibody Society

Career Center

Our Career Center is a premier resource to connect highly qualified talent with matching career opportunities. Visit for details on over 800 jobs!

AIRR Community

AIRR Community

The Adaptive Immune Receptor Repertoire Community is a research-driven group organizing around the use of high-throughput sequencing technologies to study antibody/B-cell and T-cell receptor repertoires.

Recent Posts

  • The Antibody Society announces the election of new Directors and Officers January 26, 2023
  • AIRR Data Commons and iReceptor Science Gateway Start Major Collaboration with Type-1 Diabetes Researchers January 11, 2023
  • FDA approves Leqembi (lecanemab-irmb) for the treatment of Alzheimer’s disease January 6, 2023

Archives

Follow us online

  • Email
  • LinkedIn
  • Twitter
  • YouTube
  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals